| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Shannon James Samuel is a Director at Xilio Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $770K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | XLO Xilio Therapeutics, Inc. | - | Buy | 70,000 | $0.69 | $48,085.00 | +155.6% | +13.0% | - |